These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26983714)

  • 1. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
    Cong XQ; Piao MH; Li Y; Xie L; Liu Y
    Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; Thompson KH; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins.
    Lakshmanan AP; Harima M; Suzuki K; Soetikno V; Nagata M; Nakamura T; Takahashi T; Sone H; Kawachi H; Watanabe K
    Int J Biochem Cell Biol; 2013 Feb; 45(2):438-47. PubMed ID: 23032698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
    Marzban L; Rahimian R; Brownsey RW; McNeill JH
    Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats.
    Yuen VG; Orvig C; McNeill JH
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E30-5. PubMed ID: 9038848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats.
    Bhanot S; Girn J; Poucheret P; McNeill JH
    Mol Cell Biochem; 1999 Dec; 202(1-2):131-40. PubMed ID: 10706003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
    Shinde UA; Mehta AA; Goyal RK
    Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
    Marzban L; Bhanot S; McNeill JH
    Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway.
    Sun S; Yang S; An N; Wang G; Xu Q; Liu J; Mao Y
    J Ethnopharmacol; 2019 Jun; 238():111857. PubMed ID: 30959142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
    Kordowiak AM; Dziga D; Dabroś W
    Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats.
    Yuen VG; Vera E; Battell ML; Li WM; McNeill JH
    Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism.
    Guo R; Liu W; Liu B; Zhang B; Li W; Xu Y
    Int J Cardiol; 2015 Jul; 191():36-45. PubMed ID: 25965594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats.
    Li SH; McNeill JH
    Mol Cell Biochem; 2001 Jan; 217(1-2):121-9. PubMed ID: 11269655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
    Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
    Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.
    Winter PW; Al-Qatati A; Wolf-Ringwall AL; Schoeberl S; Chatterjee PB; Barisas BG; Roess DA; Crans DC
    Dalton Trans; 2012 Jun; 41(21):6419-30. PubMed ID: 22569684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.
    Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J
    ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.